NovaBay, like Oculus, seems to have discovered that diluted bleach kills most micro-organisms. However, NovaBay seems to have a better grasp than Oculus of the clinical trial process and also a better valuation at this moment in time. At a sub-50M… More
Over the last six months, NovaBay has been reanimated from the low of 0.7 that followed the abject failure of aganocide NVC-422 in a phase II trial for viral conjunctivitis. The decline was exacerbated by dilutive financing and the general distaste… More